TY - JOUR
T1 - Infective Endocarditis Following Transcatheter Aortic Valve Replacement
T2 - Comparison of Balloon- Versus Self-Expandable Valves
AU - Regueiro, Ander
AU - Linke, Axel
AU - Latib, Azeem
AU - Ihlemann, Nikolaj
AU - Urena, Marina
AU - Walther, Thomas
AU - Husser, Oliver
AU - Herrmann, Howard
AU - Nombela-Franco, Luis
AU - Cheema, Asim
AU - Le Breton, Hervé
AU - Stortecky, Stefan
AU - Kapadia, Samir
AU - Bartorelli, Antonio
AU - Sinning, Jan Malte
AU - Amat-Santos, Ignacio
AU - Munoz-Garcia, Antonio
AU - Lerakis, Stamatios
AU - Gutíerrez-Ibanes, Enrique
AU - Abdel-Wahab, Mohamed
AU - Tchetche, Didier
AU - Testa, Luca
AU - Eltchaninoff, Helene
AU - Livi, Ugolino
AU - Castillo, Juan Carlos
AU - Jilaihawi, Hasan
AU - Webb, John
AU - Barbanti, Marco
AU - Kodali, Susheel
AU - de Brito Jr, Fabio
AU - Ribeiro, Henrique
AU - Miceli, Antonio
AU - Fiorina, Claudia
AU - Actis Dato, Guglielmo Mario
AU - Rosato, Francesco
AU - Serra, Vicenç
AU - Masson, Jean-Bernard
AU - Wijeysundera, Harindra
AU - Mangione, Jose
AU - Ferreira, Maria-Cristina
AU - Lima, Valter
AU - Carvalho, Luis
AU - Abizaid, Alexandre
AU - Marino, Marcos
AU - Esteves, Vinicius
AU - Andrea, Julio
AU - Messika-Zeitoun, David
AU - Himbert, Dominique
AU - Kim, Won-Keun
AU - Pellegrini, Costanza
AU - Auffret, Vincent
AU - Nietlispach, Fabian
AU - Pilgrim, Thomas
AU - Durand, Eric
AU - Lisko, John
AU - Makkar, Raj
AU - Lemos, Pedro
AU - Leon, Martin
AU - Puri, Rishi
AU - San Roman, Alberto
AU - Vahanian, Alec
AU - Søndergaard, Lars
AU - Mangner, Norman
AU - Rodés-Cabau, Josep
PY - 2019
Y1 - 2019
N2 - BACKGROUND: No data exist about the characteristics of infective endocarditis (IE) post-transcatheter aortic valve replacement (TAVR) according to transcatheter valve type. We aimed to determine the incidence, clinical characteristics, and outcomes of patients with IE post-TAVR treated with balloon-expandable valve (BEV) versus self-expanding valve (SEV) systems.METHODS: Data from the multicenter Infectious Endocarditis After TAVR International Registry was used to compare IE patients with BEV versus SEV.RESULTS: A total of 245 patients with IE post-TAVR were included (SEV, 47%; BEV, 53%). The timing between TAVR and IE was similar between groups (SEV, 5.5 [1.2-15] months versus BEV, 5.3 [1.7-11.4] months; P=0.89). Enterococcal IE was more frequent in the SEV group (36.5% versus 15.4%; P<0.01), and vegetation location differed according to valve type (stent frame, SEV, 18.6%; BEV, 6.9%; P=0.01; valve leaflet, SEV, 23.9%; BEV, 38.5%; P=0.01). BEV recipients had a higher rate of stroke/systemic embolism (20.0% versus 8.7%, adjusted OR: 2.46, 95% CI: 1.04-5.82, P=0.04). Surgical explant of the transcatheter valve (SEV, 8.7%; BEV, 13.8%; P=0.21), and in-hospital death at the time of IE episode (SEV, 35.6%; BEV, 37.7%; P=0.74) were similar between groups. After a mean follow-up of 13±12 months, 59.1% and 54.6% of the SEV and BEV recipients, respectively, had died (P=0.66).CONCLUSIONS: The characteristics of IE post-TAVR, including microorganism type, vegetation location, and embolic complications but not early or late mortality, differed according to valve type. These results may help to guide the diagnosis and management of IE and inform future research studies in the field.
AB - BACKGROUND: No data exist about the characteristics of infective endocarditis (IE) post-transcatheter aortic valve replacement (TAVR) according to transcatheter valve type. We aimed to determine the incidence, clinical characteristics, and outcomes of patients with IE post-TAVR treated with balloon-expandable valve (BEV) versus self-expanding valve (SEV) systems.METHODS: Data from the multicenter Infectious Endocarditis After TAVR International Registry was used to compare IE patients with BEV versus SEV.RESULTS: A total of 245 patients with IE post-TAVR were included (SEV, 47%; BEV, 53%). The timing between TAVR and IE was similar between groups (SEV, 5.5 [1.2-15] months versus BEV, 5.3 [1.7-11.4] months; P=0.89). Enterococcal IE was more frequent in the SEV group (36.5% versus 15.4%; P<0.01), and vegetation location differed according to valve type (stent frame, SEV, 18.6%; BEV, 6.9%; P=0.01; valve leaflet, SEV, 23.9%; BEV, 38.5%; P=0.01). BEV recipients had a higher rate of stroke/systemic embolism (20.0% versus 8.7%, adjusted OR: 2.46, 95% CI: 1.04-5.82, P=0.04). Surgical explant of the transcatheter valve (SEV, 8.7%; BEV, 13.8%; P=0.21), and in-hospital death at the time of IE episode (SEV, 35.6%; BEV, 37.7%; P=0.74) were similar between groups. After a mean follow-up of 13±12 months, 59.1% and 54.6% of the SEV and BEV recipients, respectively, had died (P=0.66).CONCLUSIONS: The characteristics of IE post-TAVR, including microorganism type, vegetation location, and embolic complications but not early or late mortality, differed according to valve type. These results may help to guide the diagnosis and management of IE and inform future research studies in the field.
U2 - 10.1161/CIRCINTERVENTIONS.119.007938
DO - 10.1161/CIRCINTERVENTIONS.119.007938
M3 - Journal article
C2 - 31694412
SN - 1941-7640
VL - 12
SP - e007938
JO - Circulation. Cardiovascular interventions
JF - Circulation. Cardiovascular interventions
IS - 11
ER -